Plus Jon Willis’s “The Pale Blue Data Point.” ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

Fintel reports that on January 9, 2026, B. Riley Securities initiated coverage of Palisade Bio (NasdaqCM:PALI) with a Buy recommendation. Analyst Price Forecast Suggests 499.50% Upside As of December ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

"Across the GCC there's a hunger for measurable and science-backed longevity. People want data, they want speed, and they act on it," says wellness expert Aly Rahimtoola ...

Fintel reports that on January 7, 2026, UBS initiated coverage of Nuvation Bio (NYSE:NUVB) with a Neutral recommendation.

The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

Artificial intelligence is quietly transforming how scientists monitor and manage invisible biological pollutants in rivers, ...

Arrowhead’s RNA drugs could aid with “high-quality” weight loss, according to one analyst. Elsewhere, the PD-1/VEGF field got ...

Venture capitalist Meltem Demirors isn’t above the occasional splurge on bags, jewelry and other material things. But she ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...